Cell Line for Production of Recombinant Human Tissue Inhibitor of Metalloproteinase-2

Provided by: National Institutes of Health (NIH)
Tags: Tumor Suppressor Ischemic Diseases TIMP-2 HEK-293F cell line Myocardial Infarct cancer Neurodegenerative Diseases
Short Description:

This technology envelops a unique HEK-293F cell line which stably expresses rhTIMP-2, increasing the production of TIMP-2 to quantities sufficient for testing and developing therapies.

Projects based on this Technology

Start New Project